Page 37 - Lipids News Today

Using artificial intelligence to analyze large amounts of information from social media platforms generated novel insights into public perceptions about statins, results of a new study show.

A recent study showed a discrepancy between the target levels of LDL cholesterol stipulated in European guidelines and the levels achieved in clinical practice.

Treatment with a topical antioxidant plus nonablative laser therapy reduced postinflammatory erythema and hyperpigmentation associated with acne lesions, in a prospective study of 24 patients.

A medical expert discusses preauthorization requests and requirements for cardiovascular disease treatment, commenting on an abstract presented at the ACC 2023 Annual Scientific Session and Expo and World Congress of Cardiology.

Initiation of statins soon after diagnosis of AF is associated with lower risk of ischemic and hemorrhagic strokes; longer-term use is tied to further benefit, a new study shows.

As of April 18, the USPTO has switched to providing patent grants electronically. This means that instead of mailing a physical copy of the patent grant to the correspondence address, the USPTO will provide the patent grant electronically via the Patent Center.

There is no difference in the risk of myocardial infarction with interleukin-6 (IL-6) vs anti-tumor necrosis factor (TNF) therapy for rheumatoid arthritis.

Major depressive disorder is linked to disruptions in energy and lipid metabolism, possibly caused by the interplay of the gut microbiome and blood metabolome.

1. High-sensitivity CRP increased the risk of all-cause mortality by two- to three-fold among all three randomized trials. 2. The effect of residual cholesterol on major cardiovascular events, cardiovascular mortality, and all-cause mortality was insignificant. Evidence Rating Level: 1 (Excellent) Study Rundown: Statins are first-line therapy in patients with clinical atherosclerosis. While inflammation and hyperlipidemia

In this interview conducted at Pittcon 2023 in Philadelphia, Pennsylvania, we spoke to Professor Albert Heck and gained a mass spectrometrist's perspective on the field of glycobiology.